China’s CanSino Pushing for Early Authorization for COVID-19 Vaccine

China’s CanSino Biologics is currently lobbying regulators abroad to grant its vaccine candidate the equivalent of the U.S. Food and Drug Administration’s emergency use authorization (EUA). The …
( read original story …)